1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Phage Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 DsDNA Bacteriophage 1.2.3 SsDNA Bacteriophage 1.2.4 SsRNA Bacteriophage 1.2.5 Others 1.3 Market by Application 1.3.1 Global Phage Therapy Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Animal Health 1.3.3 Aquaculture 1.3.4 Agriculture 1.3.5 Food Industry 1.3.6 Human Health 1.3.7 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Phage Therapy Market Perspective (2017-2028) 2.2 Phage Therapy Growth Trends by Region 2.2.1 Phage Therapy Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Phage Therapy Historic Market Size by Region (2017-2022) 2.2.3 Phage Therapy Forecasted Market Size by Region (2023-2028) 2.3 Phage Therapy Market Dynamics 2.3.1 Phage Therapy Industry Trends 2.3.2 Phage Therapy Market Drivers 2.3.3 Phage Therapy Market Challenges 2.3.4 Phage Therapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Phage Therapy Players by Revenue 3.1.1 Global Top Phage Therapy Players by Revenue (2017-2022) 3.1.2 Global Phage Therapy Revenue Market Share by Players (2017-2022) 3.2 Global Phage Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Phage Therapy Revenue 3.4 Global Phage Therapy Market Concentration Ratio 3.4.1 Global Phage Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Phage Therapy Revenue in 2021 3.5 Phage Therapy Key Players Head office and Area Served 3.6 Key Players Phage Therapy Product Solution and Service 3.7 Date of Enter into Phage Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Phage Therapy Breakdown Data by Type 4.1 Global Phage Therapy Historic Market Size by Type (2017-2022) 4.2 Global Phage Therapy Forecasted Market Size by Type (2023-2028) 5 Phage Therapy Breakdown Data by Application 5.1 Global Phage Therapy Historic Market Size by Application (2017-2022) 5.2 Global Phage Therapy Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Phage Therapy Market Size (2017-2028) 6.2 North America Phage Therapy Market Size by Country (2017-2022) 6.3 North America Phage Therapy Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Phage Therapy Market Size (2017-2028) 7.2 Europe Phage Therapy Market Size by Country (2017-2022) 7.3 Europe Phage Therapy Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Phage Therapy Market Size (2017-2028) 8.2 Asia-Pacific Phage Therapy Market Size by Country (2017-2022) 8.3 Asia-Pacific Phage Therapy Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Phage Therapy Market Size (2017-2028) 9.2 Latin America Phage Therapy Market Size by Country (2017-2022) 9.3 Latin America Phage Therapy Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Phage Therapy Market Size (2017-2028) 10.2 Middle East & Africa Phage Therapy Market Size by Country (2017-2022) 10.3 Middle East & Africa Phage Therapy Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 NPO Microgen 11.1.1 NPO Microgen Company Detail 11.1.2 NPO Microgen Business Overview 11.1.3 NPO Microgen Phage Therapy Introduction 11.1.4 NPO Microgen Revenue in Phage Therapy Business (2017-2022) 11.1.5 NPO Microgen Recent Development 11.2 Proteon Pharmaceuticals 11.2.1 Proteon Pharmaceuticals Company Detail 11.2.2 Proteon Pharmaceuticals Business Overview 11.2.3 Proteon Pharmaceuticals Phage Therapy Introduction 11.2.4 Proteon Pharmaceuticals Revenue in Phage Therapy Business (2017-2022) 11.2.5 Proteon Pharmaceuticals Recent Development 11.3 Phagelux 11.3.1 Phagelux Company Detail 11.3.2 Phagelux Business Overview 11.3.3 Phagelux Phage Therapy Introduction 11.3.4 Phagelux Revenue in Phage Therapy Business (2017-2022) 11.3.5 Phagelux Recent Development 11.4 Intralytix 11.4.1 Intralytix Company Detail 11.4.2 Intralytix Business Overview 11.4.3 Intralytix Phage Therapy Introduction 11.4.4 Intralytix Revenue in Phage Therapy Business (2017-2022) 11.4.5 Intralytix Recent Development 11.5 Micreos 11.5.1 Micreos Company Detail 11.5.2 Micreos Business Overview 11.5.3 Micreos Phage Therapy Introduction 11.5.4 Micreos Revenue in Phage Therapy Business (2017-2022) 11.5.5 Micreos Recent Development 11.6 Eliava BioPreparations 11.6.1 Eliava BioPreparations Company Detail 11.6.2 Eliava BioPreparations Business Overview 11.6.3 Eliava BioPreparations Phage Therapy Introduction 11.6.4 Eliava BioPreparations Revenue in Phage Therapy Business (2017-2022) 11.6.5 Eliava BioPreparations Recent Development 11.7 Locus Biosciences,Inc 11.7.1 Locus Biosciences,Inc Company Detail 11.7.2 Locus Biosciences,Inc Business Overview 11.7.3 Locus Biosciences,Inc Phage Therapy Introduction 11.7.4 Locus Biosciences,Inc Revenue in Phage Therapy Business (2017-2022) 11.7.5 Locus Biosciences,Inc Recent Development 11.8 Pharmex Group,LLC 11.8.1 Pharmex Group,LLC Company Detail 11.8.2 Pharmex Group,LLC Business Overview 11.8.3 Pharmex Group,LLC Phage Therapy Introduction 11.8.4 Pharmex Group,LLC Revenue in Phage Therapy Business (2017-2022) 11.8.5 Pharmex Group,LLC Recent Development 11.9 Pherecydes Pharma 11.9.1 Pherecydes Pharma Company Detail 11.9.2 Pherecydes Pharma Business Overview 11.9.3 Pherecydes Pharma Phage Therapy Introduction 11.9.4 Pherecydes Pharma Revenue in Phage Therapy Business (2017-2022) 11.9.5 Pherecydes Pharma Recent Development 11.10 APS Biocontrol Ltd. (APS) 11.10.1 APS Biocontrol Ltd. (APS) Company Detail 11.10.2 APS Biocontrol Ltd. (APS) Business Overview 11.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Introduction 11.10.4 APS Biocontrol Ltd. (APS) Revenue in Phage Therapy Business (2017-2022) 11.10.5 APS Biocontrol Ltd. (APS) Recent Development 11.11 Qingdao Phagepharm Bio-tech 11.11.1 Qingdao Phagepharm Bio-tech Company Detail 11.11.2 Qingdao Phagepharm Bio-tech Business Overview 11.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Introduction 11.11.4 Qingdao Phagepharm Bio-tech Revenue in Phage Therapy Business (2017-2022) 11.11.5 Qingdao Phagepharm Bio-tech Recent Development 11.12 Fixed-Phage Limited 11.12.1 Fixed-Phage Limited Company Detail 11.12.2 Fixed-Phage Limited Business Overview 11.12.3 Fixed-Phage Limited Phage Therapy Introduction 11.12.4 Fixed-Phage Limited Revenue in Phage Therapy Business (2017-2022) 11.12.5 Fixed-Phage Limited Recent Development 11.13 Zeptometrix 11.13.1 Zeptometrix Company Detail 11.13.2 Zeptometrix Business Overview 11.13.3 Zeptometrix Phage Therapy Introduction 11.13.4 Zeptometrix Revenue in Phage Therapy Business (2017-2022) 11.13.5 Zeptometrix Recent Development 11.14 Phage International, Inc. 11.14.1 Phage International, Inc. Company Detail 11.14.2 Phage International, Inc. Business Overview 11.14.3 Phage International, Inc. Phage Therapy Introduction 11.14.4 Phage International, Inc. Revenue in Phage Therapy Business (2017-2022) 11.14.5 Phage International, Inc. Recent Development 11.15 MicroMir 11.15.1 MicroMir Company Detail 11.15.2 MicroMir Business Overview 11.15.3 MicroMir Phage Therapy Introduction 11.15.4 MicroMir Revenue in Phage Therapy Business (2017-2022) 11.15.5 MicroMir Recent Development 11.16 iNtODEWORLD, Inc. 11.16.1 iNtODEWORLD, Inc. Company Detail 11.16.2 iNtODEWORLD, Inc. Business Overview 11.16.3 iNtODEWORLD, Inc. Phage Therapy Introduction 11.16.4 iNtODEWORLD, Inc. Revenue in Phage Therapy Business (2017-2022) 11.16.5 iNtODEWORLD, Inc. Recent Development 11.17 NEXTBIOTICS 11.17.1 NEXTBIOTICS Company Detail 11.17.2 NEXTBIOTICS Business Overview 11.17.3 NEXTBIOTICS Phage Therapy Introduction 11.17.4 NEXTBIOTICS Revenue in Phage Therapy Business (2017-2022) 11.17.5 NEXTBIOTICS Recent Development 11.18 Armata Pharmaceuticals, Inc. 11.18.1 Armata Pharmaceuticals, Inc. Company Detail 11.18.2 Armata Pharmaceuticals, Inc. Business Overview 11.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Introduction 11.18.4 Armata Pharmaceuticals, Inc. Revenue in Phage Therapy Business (2017-2022) 11.18.5 Armata Pharmaceuticals, Inc. Recent Development 11.19 Innophage 11.19.1 Innophage Company Detail 11.19.2 Innophage Business Overview 11.19.3 Innophage Phage Therapy Introduction 11.19.4 Innophage Revenue in Phage Therapy Business (2017-2022) 11.19.5 Innophage Recent Development 11.20 Adaptive Phage Therapeutics 11.20.1 Adaptive Phage Therapeutics Company Detail 11.20.2 Adaptive Phage Therapeutics Business Overview 11.20.3 Adaptive Phage Therapeutics Phage Therapy Introduction 11.20.4 Adaptive Phage Therapeutics Revenue in Phage Therapy Business (2017-2022) 11.20.5 Adaptive Phage Therapeutics Recent Development 11.21 TechnoPhage 11.21.1 TechnoPhage Company Detail 11.21.2 TechnoPhage Business Overview 11.21.3 TechnoPhage Phage Therapy Introduction 11.21.4 TechnoPhage Revenue in Phage Therapy Business (2017-2022) 11.21.5 TechnoPhage Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Phage Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of DsDNA Bacteriophage Table 3. Key Players of SsDNA Bacteriophage Table 4. Key Players of SsRNA Bacteriophage Table 5. Key Players of Others Table 6. Global Phage Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Phage Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Phage Therapy Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Phage Therapy Market Share by Region (2017-2022) Table 10. Global Phage Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Phage Therapy Market Share by Region (2023-2028) Table 12. Phage Therapy Market Trends Table 13. Phage Therapy Market Drivers Table 14. Phage Therapy Market Challenges Table 15. Phage Therapy Market Restraints Table 16. Global Phage Therapy Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Phage Therapy Market Share by Players (2017-2022) Table 18. Global Top Phage Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phage Therapy as of 2021) Table 19. Ranking of Global Top Phage Therapy Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Phage Therapy Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Phage Therapy Product Solution and Service Table 23. Date of Enter into Phage Therapy Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Phage Therapy Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Phage Therapy Revenue Market Share by Type (2017-2022) Table 27. Global Phage Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Phage Therapy Revenue Market Share by Type (2023-2028) Table 29. Global Phage Therapy Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Phage Therapy Revenue Market Share by Application (2017-2022) Table 31. Global Phage Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Phage Therapy Revenue Market Share by Application (2023-2028) Table 33. North America Phage Therapy Market Size by Country (2017-2022) & (US$ Million) Table 34. North America Phage Therapy Market Size by Country (2023-2028) & (US$ Million) Table 35. Europe Phage Therapy Market Size by Country (2017-2022) & (US$ Million) Table 36. Europe Phage Therapy Market Size by Country (2023-2028) & (US$ Million) Table 37. Asia-Pacific Phage Therapy Market Size by Region (2017-2022) & (US$ Million) Table 38. Asia-Pacific Phage Therapy Market Size by Region (2023-2028) & (US$ Million) Table 39. Latin America Phage Therapy Market Size by Country (2017-2022) & (US$ Million) Table 40. Latin America Phage Therapy Market Size by Country (2023-2028) & (US$ Million) Table 41. Middle East & Africa Phage Therapy Market Size by Country (2017-2022) & (US$ Million) Table 42. Middle East & Africa Phage Therapy Market Size by Country (2023-2028) & (US$ Million) Table 43. NPO Microgen Company Detail Table 44. NPO Microgen Business Overview Table 45. NPO Microgen Phage Therapy Product Table 46. NPO Microgen Revenue in Phage Therapy Business (2017-2022) & (US$ Million) Table 47. NPO Microgen Recent Development Table 48. Proteon Pharmaceuticals Company Detail Table 49. Proteon Pharmaceuticals Business Overview Table 50. Proteon Pharmaceuticals Phage Therapy Product Table 51. Proteon Pharmaceuticals Revenue in Phage Therapy Business (2017-2022) & (US$ Million) Table 52. Proteon Pharmaceuticals Recent Development Table 53. Phagelux Company Detail Table 54. Phagelux Business Overview Table 55. Phagelux Phage Therapy Product Table 56. Phagelux Revenue in Phage Therapy Business (2017-2022) & (US$ Million) Table 57. Phagelux Recent Development Table 58. Intralytix Company Detail Table 59. Intralytix Business Overview Table 60. Intralytix Phage Therapy Product Table 61. Intralytix Revenue in Phage Therapy Business (2017-2022) & (US$ Million) Table 62. Intralytix Recent Development Table 63. Micreos Company Detail Table 64. Micreos Business Overview Table 65. Micreos Phage Therapy Product Table 66. Micreos Revenue in Phage Therapy Business (2017-2022) & (US$ Million) Table 67. Micreos Recent Development Table 68. Eliava BioPreparations Company Detail Table 69. Eliava BioPreparations Business Overview Table 70. Eliava BioPreparations Phage Therapy Product Table 71. Eliava BioPreparations Revenue in Phage Therapy Business (2017-2022) & (US$ Million) Table 72. Eliava BioPreparations Recent Development Table 73. Locus Biosciences,Inc Company Detail Table 74. Locus Biosciences,Inc Business Overview Table 75. Locus Biosciences,Inc Phage Therapy Product Table 76. Locus Biosciences,Inc Revenue in Phage Therapy Business (2017-2022) & (US$ Million) Table 77. Locus Biosciences,Inc Recent Development Table 78. Pharmex Group,LLC Company Detail Table 79. Pharmex Group,LLC Business Overview Table 80. Pharmex Group,LLC Phage Therapy Product Table 81. Pharmex Group,LLC Revenue in Phage Therapy Business (2017-2022) & (US$ Million) Table 82. Pharmex Group,LLC Recent Development Table 83. Pherecydes Pharma Company Detail Table 84. Pherecydes Pharma Business Overview Table 85. Pherecydes Pharma Phage Therapy Product Table 86. Pherecydes Pharma Revenue in Phage Therapy Business (2017-2022) & (US$ Million) Table 87. Pherecydes Pharma Recent Development Table 88. APS Biocontrol Ltd. (APS) Company Detail Table 89. APS Biocontrol Ltd. (APS) Business Overview Table 90. APS Biocontrol Ltd. (APS) Phage Therapy Product Table 91. APS Biocontrol Ltd. (APS) Revenue in Phage Therapy Business (2017-2022) & (US$ Million) Table 92. APS Biocontrol Ltd. (APS) Recent Development Table 93. Qingdao Phagepharm Bio-tech Company Detail Table 94. Qingdao Phagepharm Bio-tech Business Overview Table 95. Qingdao Phagepharm Bio-tech Phage TherapyProduct Table 96. Qingdao Phagepharm Bio-tech Revenue in Phage Therapy Business (2017-2022) & (US$ Million) Table 97. Qingdao Phagepharm Bio-tech Recent Development Table 98. Fixed-Phage Limited Company Detail Table 99. Fixed-Phage Limited Business Overview Table 100. Fixed-Phage Limited Phage TherapyProduct Table 101. Fixed-Phage Limited Revenue in Phage Therapy Business (2017-2022) & (US$ Million) Table 102. Fixed-Phage Limited Recent Development Table 103. Zeptometrix Company Detail Table 104. Zeptometrix Business Overview Table 105. Zeptometrix Phage TherapyProduct Table 106. Zeptometrix Revenue in Phage Therapy Business (2017-2022) & (US$ Million) Table 107. Zeptometrix Recent Development Table 108. Phage International, Inc. Company Detail Table 109. Phage International, Inc. Business Overview Table 110. Phage International, Inc. Phage TherapyProduct Table 111. Phage International, Inc. Revenue in Phage Therapy Business (2017-2022) & (US$ Million) Table 112. Phage International, Inc. Recent Development Table 113. MicroMir Company Detail Table 114. MicroMir Business Overview Table 115. MicroMir Phage TherapyProduct Table 116. MicroMir Revenue in Phage Therapy Business (2017-2022) & (US$ Million) Table 117. MicroMir Recent Development Table 118. iNtODEWORLD, Inc. Company Detail Table 119. iNtODEWORLD, Inc. Business Overview Table 120. iNtODEWORLD, Inc. Phage TherapyProduct Table 121. iNtODEWORLD, Inc. Revenue in Phage Therapy Business (2017-2022) & (US$ Million) Table 122. iNtODEWORLD, Inc. Recent Development Table 123. NEXTBIOTICS Company Detail Table 124. NEXTBIOTICS Business Overview Table 125. NEXTBIOTICS Phage TherapyProduct Table 126. NEXTBIOTICS Revenue in Phage Therapy Business (2017-2022) & (US$ Million) Table 127. NEXTBIOTICS Recent Development Table 128. Armata Pharmaceuticals, Inc. Company Detail Table 129. Armata Pharmaceuticals, Inc. Business Overview Table 130. Armata Pharmaceuticals, Inc. Phage TherapyProduct Table 131. Armata Pharmaceuticals, Inc. Revenue in Phage Therapy Business (2017-2022) & (US$ Million) Table 132. Armata Pharmaceuticals, Inc. Recent Development Table 133. Innophage Company Detail Table 134. Innophage Business Overview Table 135. Innophage Phage TherapyProduct Table 136. Innophage Revenue in Phage Therapy Business (2017-2022) & (US$ Million) Table 137. Innophage Recent Development Table 138. Adaptive Phage Therapeutics Company Detail Table 139. Adaptive Phage Therapeutics Business Overview Table 140. Adaptive Phage Therapeutics Phage TherapyProduct Table 141. Adaptive Phage Therapeutics Revenue in Phage Therapy Business (2017-2022) & (US$ Million) Table 142. Adaptive Phage Therapeutics Recent Development Table 143. TechnoPhage Company Detail Table 144. TechnoPhage Business Overview Table 145. TechnoPhage Phage TherapyProduct Table 146. TechnoPhage Revenue in Phage Therapy Business (2017-2022) & (US$ Million) Table 147. TechnoPhage Recent Development Table 148. Research Programs/Design for This Report Table 149. Key Data Information from Secondary Sources Table 150. Key Data Information from Primary Sources List of Figures Figure 1. Global Phage Therapy Market Share by Type: 2021 VS 2028 Figure 2. DsDNA Bacteriophage Features Figure 3. SsDNA Bacteriophage Features Figure 4. SsRNA Bacteriophage Features Figure 5. Others Features Figure 6. Global Phage Therapy Market Share by Application in 2021 & 2028 Figure 7. Animal Health Case Studies Figure 8. Aquaculture Case Studies Figure 9. Agriculture Case Studies Figure 10. Food Industry Case Studies Figure 11. Human Health Case Studies Figure 12. Others Case Studies Figure 13. Phage Therapy Report Years Considered Figure 14. Global Phage Therapy Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 15. Global Phage Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 16. Global Phage Therapy Market Share by Region: 2021 VS 2028 Figure 17. Global Phage Therapy Market Share by Players in 2021 Figure 18. Global Top Phage Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phage Therapy as of 2021) Figure 19. The Top 10 and 5 Players Market Share by Phage Therapy Revenue in 2021 Figure 20. North America Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. North America Phage Therapy Market Share by Country (2017-2028) Figure 22. United States Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Canada Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Europe Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Europe Phage Therapy Market Share by Country (2017-2028) Figure 26. Germany Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. France Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. U.K. Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Italy Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Russia Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Nordic Countries Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Asia-Pacific Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Asia-Pacific Phage Therapy Market Share by Region (2017-2028) Figure 34. China Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Japan Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. South Korea Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Southeast Asia Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. India Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Australia Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Latin America Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Latin America Phage Therapy Market Share by Country (2017-2028) Figure 42. Mexico Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Brazil Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Middle East & Africa Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Middle East & Africa Phage Therapy Market Share by Country (2017-2028) Figure 46. Turkey Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Saudi Arabia Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. NPO Microgen Revenue Growth Rate in Phage Therapy Business (2017-2022) Figure 49. Proteon Pharmaceuticals Revenue Growth Rate in Phage Therapy Business (2017-2022) Figure 50. Phagelux Revenue Growth Rate in Phage Therapy Business (2017-2022) Figure 51. Intralytix Revenue Growth Rate in Phage Therapy Business (2017-2022) Figure 52. Micreos Revenue Growth Rate in Phage Therapy Business (2017-2022) Figure 53. Eliava BioPreparations Revenue Growth Rate in Phage Therapy Business (2017-2022) Figure 54. Locus Biosciences,Inc Revenue Growth Rate in Phage Therapy Business (2017-2022) Figure 55. Pharmex Group,LLC Revenue Growth Rate in Phage Therapy Business (2017-2022) Figure 56. Pherecydes Pharma Revenue Growth Rate in Phage Therapy Business (2017-2022) Figure 57. APS Biocontrol Ltd. (APS) Revenue Growth Rate in Phage Therapy Business (2017-2022) Figure 58. Qingdao Phagepharm Bio-tech Revenue Growth Rate in Phage Therapy Business (2017-2022) Figure 59. Fixed-Phage Limited Revenue Growth Rate in Phage Therapy Business (2017-2022) Figure 60. Zeptometrix Revenue Growth Rate in Phage Therapy Business (2017-2022) Figure 61. Phage International, Inc. Revenue Growth Rate in Phage Therapy Business (2017-2022) Figure 62. MicroMir Revenue Growth Rate in Phage Therapy Business (2017-2022) Figure 63. iNtODEWORLD, Inc. Revenue Growth Rate in Phage Therapy Business (2017-2022) Figure 64. NEXTBIOTICS Revenue Growth Rate in Phage Therapy Business (2017-2022) Figure 65. Armata Pharmaceuticals, Inc. Revenue Growth Rate in Phage Therapy Business (2017-2022) Figure 66. Innophage Revenue Growth Rate in Phage Therapy Business (2017-2022) Figure 67. Adaptive Phage Therapeutics Revenue Growth Rate in Phage Therapy Business (2017-2022) Figure 68. TechnoPhage Revenue Growth Rate in Phage Therapy Business (2017-2022) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed

NPO Microgen Proteon Pharmaceuticals Phagelux Intralytix Micreos Eliava BioPreparations Locus Biosciences,Inc Pharmex Group,LLC Pherecydes Pharma APS Biocontrol Ltd. (APS) Qingdao Phagepharm Bio-tech Fixed-Phage Limited Zeptometrix Phage International, Inc. MicroMir iNtODEWORLD, Inc. NEXTBIOTICS Armata Pharmaceuticals, Inc. Innophage Adaptive Phage Therapeutics TechnoPhage